Akanda (AKAN) Total Liabilities (2020 - 2025)
Akanda's (AKAN) quarterly Total Liabilities came in at $18.2 million in Q4 2025, up 399.95% year-on-year from $3.6 million in Q4 2024, and up 524.13% quarter-over-quarter from $2.9 million in Q2 2025.
Akanda (AKAN) Total Liabilities (2020 - 2025) Analysis & Trends
Akanda's Total Liabilities history runs 6 years deep, the most recent figure standing at $18.2 million for Q4 2025.
- On a quarterly basis, Total Liabilities rose 399.95% year-over-year to $18.2 million in Q4 2025; TTM through Dec 2025 was $18.2 million, a 399.95% increase from a year earlier, with the FY2025 full-year figure at $18.2 million, up 399.95% from the prior year.
- Total Liabilities rose to $18.2 million in Q4 2025 per AKAN's latest filing, from $2.9 million in the prior quarter.
- Across five years, Total Liabilities topped out at $18.2 million in Q4 2025 and bottomed at $2.9 million in Q2 2025.
- The 5-year median for Total Liabilities is $10.2 million (2021), against an average of $9.9 million.
- Across the five-year window, Total Liabilities sank 71.29% in 2024 and jumped 399.95% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $10.2 million in 2021, then gained by 18.05% to $12.1 million in 2022, then climbed by 4.73% to $12.7 million in 2023, then sank by 71.29% to $3.6 million in 2024, then soared by 399.95% to $18.2 million in 2025.
- Per Business Quant, the three latest AKAN Total Liabilities figures stand at $18.2 million (Q4 2025), $2.9 million (Q2 2025), and $3.6 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 18.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.19 Mn |
| Jun 30, 2025 | 2.91 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Jun 30, 2024 | 5.40 Mn |
| Dec 31, 2023 | 12.67 Mn |
| Jun 30, 2023 | 14.86 Mn |
| Dec 31, 2022 | 12.10 Mn |
| Jun 30, 2022 | 8.84 Mn |
| Dec 31, 2021 | 10.25 Mn |
| Dec 31, 2020 | 9.31 Mn |